Search Results 1591-1600 of 14710 for anti-TNF drugs

  1. Nintedanib (Oral Route) Description and Brand Names - Mayo Clinic

    Nintedanib belongs to the group of drugs called tyrosine kinase inhibitors. This medicine is available only with your doctor's prescription. This product is ...

  2. Meningococcal Vaccine (Intramuscular Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Bexsero; Menactra; Menomune-ACYW-135 ...

  3. Science Saturday: Novel suppression-replacement preclinical gene therapy study shows promise in long and short QT syndromes - Mayo Clinic News Network

    ... therapy study shows promise in long and short QT syndromes ... Gene therapy is a technique that treats diseases caused by defective genes by altering genes in a ...

  4. Thiothixene (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  5. Nintedanib (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  6. Future therapy for Graves' ophthalmology - Mayo Clinic

    No uniformly effective therapy exists for Graves' ophthalmology. Insights into the important role of TSH receptor and TRAb in the development of the tissue ...

  7. Vaccine guidance from Mayo Clinic

    Medicines called vaccines help your body stop an infection before it starts. Vaccines help children and adults avoid infections that can be severe or ...

  8. Menthol And Zinc Oxide (Topical Application Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Calmoseptine; Gold Bond Medicated Body Powder; Gold Star ...

  9. Overview - Military Medicine Program - Mayo Clinic Research

    We also partner with experts in research and clinical care to advance treatment options and develop products that directly improve health care for military ...

  10. A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of Chronic Spontaneous Urticaria in Adults Inadequately Controlled by H1-antihistamines - Mayo Clinic

    anti-inflammatory drugs (NSAID), that was clinically relevant (e.g. requiring hospitalization or blood transfusion) - Requirement for anti-platelet medication ...